SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:oru-97695"
 

Sökning: id:"swepub:oai:DiVA.org:oru-97695" > Dynamic Changes in ...

Dynamic Changes in Pentraxin-3 and Neprilysin in ST Segment Elevation Myocardial Infarction

Befekadu, Rahel, 1968- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Department of Laboratory Medicine, Section for Clinical Immunology and Transfusion Medicine, Örebro University Hospital, Örebro, Sweden,Cardiovascular Research Centre,Örebro Univ Hosp, Dept Lab Med, Sect Clin Immunol & Transfus Med, S-70185 Örebro, Sweden.;Örebro Univ, Fac Med & Hlth, Sch Med Sci, Cardiovasc Res Ctr, S-70185 Örebro, Sweden.
Grenegård, Magnus, 1963- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Cardiovascular Research Centre,Örebro Univ, Fac Med & Hlth, Sch Med Sci, Cardiovasc Res Ctr, S-70185 Örebro, Sweden.
Larsson, Anders (författare)
Uppsala universitet,Klinisk kemi,Uppsala Univ, Sweden
visa fler...
Christensen, Kjeld (författare)
Karlstad Central Hospital, Karlstad, Sweden,Karlstad Cent Hosp, S-65230 Karlstad, Sweden.
Ramström, Sofia, 1973- (författare)
Linköpings universitet,Örebro universitet,Institutionen för medicinska vetenskaper,Department of Clinical Chemistry, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden,Cardiovascular Research Centre,Örebro Univ, Fac Med & Hlth, Sch Med Sci, Cardiovasc Res Ctr, S-70185 Örebro, Sweden.;Linköping Univ, Dept Clin Chem, Dept Biomed & Clin Sci, S-58185 Linköping, Sweden.,Avdelningen för klinisk kemi och farmakologi,Medicinska fakulteten,Region Östergötland, Klinisk kemi
visa färre...
 (creator_code:org_t)
2022-01-26
2022
Engelska.
Ingår i: Biomedicines. - : MDPI. - 2227-9059. ; 10:2
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Pentraxin-3 (PTX3) and neprilysin have been associated with increased morbidity and mortality in chronic inflammatory disease and heart failure, but these biomarkers have been studied less in patients with ST segment elevation myocardial infarction (STEMI). We investigated the dynamic changes in these biomarkers, as well as the well-known C-reactive protein (CRP), in STEMI patients. PTX3, neprilysin and CRP were measured in samples from 165 STEMI patients, collected at the acute stage, 1-3 days after and 3 months after percutaneous coronary intervention (PCI), and from 40 healthy donors. Patient survival was followed for approximately 8 years after the PCI. As compared with samples from healthy donors, plasma levels of CRP and PTX3 were significantly increased in the acute samples and 1-3 days after PCI, but not at 3 months. CRP levels peaked at 1-3 days, while PTX3 was similarly high in both acute and 1-3 days samples. For neprilysin, no significant differences were observed at the group level. We found no significant differences when comparing patients with patent versus occluded culprit vessels or between patients having a thrombus aspiration or not. However, we found a significant reduction in survival for individuals with PTX3 above the median, both for samples collected at the acute stage and 1-3 days after PCI (p = 0.0001 and p = 0.0008, respectively). For CRP, no significant differences were observed using this approach, but patients above the reference range for healthy donors in the acute samples showed significantly lower survival (p = 0.0476). Conclusions: Survival analysis suggests that PTX3 might be a promising marker to predict mortality in this patient population.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

C-reactive protein
PTX3 protein
ST elevation myocardial infarction
neprilysin
survival analysis
thrombectomy

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy